Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-714-0 | CAS number: 1474044-77-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In acute oral testing, the LD50 was greater than 5000 mg/kg (2500 mg/kg
based on purity). One of 10 animals died at a dose of 5000 mg/kg.
In acute dermal testing, the LD50 was greater than 2 milliliters/kg or
2000 mg/kg (1000 mg/kg based on purity). No adverse effects were
observed.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study followed accepted practices for an acute oral toxicity limit test. An appropriate number of animals were used with a high dosing regime (5000 mg/kg) and 14 day observation period.
- Qualifier:
- according to guideline
- Guideline:
- other: Acute Oral Toxicity. FHSLA, CFR Title 21, para. 191.1.
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- other: Limit Test
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- Single dose of 5000 mg/kg
- No. of animals per sex per dose:
- 5 male
5 female - Control animals:
- no
- Details on study design:
5 male and 5 female rats weighing 200-239 grams were fasted for 18 hours and then individually and singly dosed by gavage.
The animals were observed for mortality and other signs of gross toxicity for 14days.
Food and water were provided ad-libitum.- Statistics:
- None necessary.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 500 mg/kg bw
- Based on:
- act. ingr.
- Mortality:
- 1 female died on day 8 post-dosing.
No males died. - Clinical signs:
- other: No clinical symptoms of poisoning occurred
- Gross pathology:
- Gastrointestinal bloat observed.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: expert judgment
- Conclusions:
- DNNSA is practically non-toxic with an oral LD50 > 2500 mg/kg.
- Executive summary:
An acute oral toxicity study (limit test) was conducted with Synex 1052, a 50% formulation of DNNSA (DI C8-C10, BRANCHED, C9 RICH, ALKYLNAPHTHALENE SULFONIC ACID). 5 male and 5 female rats weighing 200-239 grams were fasted for 18 hours and then individually and singly dosed by gavage. The animals were observed for mortality and other signs of gross toxicity for 14days. Food and water were provided ad-libitum. 1 female died on day 8 post-dosing.
No males died. No clinical symptoms of poisoning occurred. The Synex 1052 formulation is practically non-toxic with an oral LD50 > 5000 mg/kg. The DNNSA component is also practically non-toxic with an LD50 > 2,500 mg/kg.
Reference
Group |
Dose mg / kg bw |
Male |
Female |
% Mortality |
1 |
5000 |
0/5 |
1/5 |
10 |
Oral LD50 : >5,000 mg/kg
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 500 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study followed guidelines appropriate at the time of the study. 10 animals were tested at the very high concentration of 200 mg/L and no toxicity was evident.
- Qualifier:
- according to guideline
- Guideline:
- other: Acute Inhalation Study. US FHSLA, CFR, Title.21, para. 191.10.
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- fixed concentration procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The spray was introduced into the chamber via a nebulizer, was circulated and was directed away from the animals. The chamber was saturated with 200mg/liter.
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- Five male and five female Wistar rats, 200 - 300g. A group of five male and five female Wistar rats were exposed to an aerosol
of the test material in an inhalation chamber for one hour. The spray was introduced into the chamber via a nebulizer, was circulated and was directed away from the animals. The chamber was saturated with 200mg/liter, nominal, of test material prior to the period of exposure.
The rats were observed for 14 days following exposure.
exposu reo - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- ca. 1 h
- Concentrations:
- 200 mg/L
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Statistics:
- None Required
- Preliminary study:
- The study was a limit test without a preliminary exposure.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 200 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 1 h
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 100 mg/L air
- Based on:
- act. ingr.
- Exp. duration:
- 1 h
- Mortality:
- No mortality
- Clinical signs:
- other: No clinical symptoms or other adverse effects
- Body weight:
- See table - attached
- Gross pathology:
- No remarkable findings.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: other: EPA Category IV ( practically non-toxic based on LC50 greater than 20 mg/L)
- Conclusions:
- A one-hour exposure to a 50% formulation of DNNSA at 200 mg/L was not toxic to male and female Wistar rats.
- Executive summary:
Synex 1052, a 50% liquid formulation of DNNSA (DI C8-C10, BRANCHED, C9 RICH, ALKYLNAPHTHALENE SULFONIC ACID), was evaluated for acute inhalation toxicity. Five male and five female Wistar rats, (Body Wt. 200 - 300g) received a whole body exposure for one hour to an aerosol of the test material in an inhalation chamber. The spray was introduced into the chamber via a nebulizer, was circulated and was directed away from the animals. The chamber was saturated with 200 mg/liter, nominal, of test material prior to the period of exposure. The rats were observed for 14 days following exposure. In the one-hour exposure, and during the 14 day observation period, the test material did not cause mortality or clinical symptoms of poisoning. The 1-hour LC50 is > 200 mg/L of the 50% formulation of DNNSA. Based on the concentration of DNNSA, the 1-hour LC50 is > than 100 mg/L. The study reports that the result support classification as EPA Category IV (practically non-toxic based on LC50 greater than 20 mg/L).
Reference
Body Weights of Wistar Rats
Rat No. |
Sex |
Body Weight - grams |
Mortality |
1 |
M |
230 |
No |
2 |
M |
241 |
No |
3 |
M |
256 |
No |
4 |
M |
267 |
No |
5 |
M |
280 |
No |
6 |
F |
214 |
No |
7 |
F |
217 |
No |
8 |
F |
225 |
No |
9 |
F |
232 |
No |
10 |
F |
230 |
No |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study follows generally accepted practices. Result (>2 ml/kg) gives clear indication of low toxicity by dermal route.
- Qualifier:
- according to guideline
- Guideline:
- other: This test methodology follows the procedure of the US Federal Hazardous Substances Act (1973) to determine substance toxicity.
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Ten healthy mature albino rabbits of New Zealand variety were selected from the stock colony for this study. They were housed in individual
stainless steel cages. Purina Rabbit Chow and water were available ad libitum. - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The compound was applied to the moistened clipped skin of ten rabbits (five intact and
five abraded). The rabbits then were wrapped with a rubber dam. After 24 hours, the rubber dam was removed and the residue gently washed off. - Duration of exposure:
- 24 hour exposure
- Doses:
- 2 ml / kg
- No. of animals per sex per dose:
- 10 (5 abraded and 5 unabraded)
- Control animals:
- no
- Details on study design:
- The compound was applied at a dose of 2 ml per kg body weight to the moistened clipped skin of ten rabbits (five intact and
five abraded). The rabbits then were wrapped with a rubber dam. After 24 hours, the rubber dam was removed and the residue gently washed off.
The test site was examined for erythema and edema and scores were recorded daily for fourteen days. Body weights were recorded on Days 0 and 14. Rabbits were observed daily for signs of toxicity. All surviving animals were sacrificed at 14 days after treatment and a thorough necropsy was conducted. - Statistics:
- Average body weights computed.
- Preliminary study:
- Dermal LD50 > 2 ml/kg
Dermal LD0 > 2 ml/kg - Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- > 2 mL/kg bw
- Based on:
- test mat.
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 2 mL/kg bw
- Based on:
- test mat.
- Mortality:
- None.
- Clinical signs:
- other: None.
- Gross pathology:
- No abnormal effects observed.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: other: Guidelines established by the US Federal Hazardous Substances Act (1973)
- Conclusions:
- The dermal LD0 and LD50 are greater than 2 ml/kg.
- Executive summary:
Ten healthy mature albino rabbits of New Zealand variety were selected from the stock colony for this study. They were housed in individual stainless steel cages. Purina Rabbit Chow and water were available ad libitum. The compound was applied at a dose of 2 ml/kg (liquid) to the moistened clipped skin of ten rabbits (five intact and five abraded). The rabbits then were wrapped with a rubber dam. After 24 hours, the rubber dam was removed and the residue gently washed off. The test site was examined for erythema and edema and scores were recorded daily for fourteen days. Body weights were recorded on Days 0 and 14. Rabbits were observed daily for signs of toxicity. All surviving animals were sacrificed at 14 days after treatment and a thorough necropsy was conducted.
The rabbits showed no signs of toxicity and no abnormal findings were noted in the necropsy. The dermal LD0 and LD50 are greater than 2 ml/kg.
Reference
Body Weights (g)
Animal | Skin | Day 0 | Day 14 |
1 | Abraded | 2175 | 2230 |
2 | Abraded | 2370 | 2410 |
3 | Abraded | 2940 | 2990 |
4 | Abraded | 1915 | 2100 |
5 | Abraded | 2810 | 2885 |
6 | Intact | 2425 | 2510 |
7 | Intact | 2270 | 2340 |
8 | Intact | 2390 | 2465 |
9 | Intact | 2800 | 2895 |
10 | Intact | 2630 | 2720 |
Ave. | 2472.5 | 2554.5 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1 000 mg/kg bw
Additional information
The available testing showed that DNNSA has low toxicity by oral and dermal routes. Based on the results of the acute oral test (LD50 > 2500 mg/kg) it is reasonable to assume that a dose of 2000 mg/kg in the dermal study would also have shown no mortality.
Justification for selection of acute toxicity – oral endpoint
Scientifically sound study following acceptable testing procedure.
Justification for selection of acute toxicity – inhalation endpoint
The use as a lubricant additive is unlikely to result in significant
human exposure to inhalable droplets.
An inhalation study is available that was conducted with a 1 hour
exposure (4 hour exposure is required). This study showed no toxicity at
an exposure of 200 mg/Liter (Acute Inhalation Study, Report T-307,
February 27, 1978 with Synex 1052 (50% DNNSA).
Justification for selection of acute toxicity – dermal endpoint
Scientifically sound study following acceptable testing procedure.
Justification for classification or non-classification
Based on finding in acute oral, dermal and inhalative studies with the substance it can be concluded that no classification for acute toxicity by oral, dermal or inhalative route is required according to CLP (Regulation EC No 1272/2008) or DSD (Directive 67/548/EEC). Given the high viscosity and the fact that DNNSA is not a pure hydrocarbon, classification for aspiration hazards is not required. No specific target organ toxicity was observed in any of the acute studies and thus STOT single exposure classification is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.